世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Epilepsy Therapeutics Market With Impact Analysis of US Tariffs (2025 Edition)

Global Epilepsy Therapeutics Market With Impact Analysis of US Tariffs (2025 Edition)


Executive Summary Azoth Analytics has released a research report titled “Global Epilepsy Therapeutics Market (2025 Edition)” which provides an analysis of the Global Epilepsy Therapeutics indust... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Azoth Analytics
アーゾスアナリティクス
2025年10月10日 US$1,850
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
2-3営業日程度 242 英語

 

Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Epilepsy Therapeutics Market (2025 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By Route of Administration (Oral, Intravenous), By Type (Branded, Generics).

The report analyses the Epilepsy Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

The epilepsy therapeutics market is projected to experience sustained growth over the coming years, driven by increasing epilepsy prevalence, rising awareness, advancements in drug development, and greater access to healthcare across both developed and emerging markets.

Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics.

The global burden of epilepsy, affecting over 50 million people, continues to drive demand. Regions with increasing awareness and healthcare access, such as Latin America, are particularly contributing to growth as epilepsy is highly prevalent, especially in children.

High demand for paediatric epilepsy care has been observed due to rising incidence rates and population growth. There is a focus on making Anti-Epileptic Drugs more accessible in this region as awareness and diagnosis rates improve.

ページTOPに戻る


Table of Contents

Table of Content



1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Analyst Recommendations

2.1 Innovation in Drug Formulation

2.2 Telemedicine and Digital Health



3. Epilepsy Therapeutics Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Epilepsy Therapeutics Market

3.2 Global Prevalence of Infectious Disease, 2019

3.3 Global Incidence of Infectious Disease, 2019

3.4 Major Epilepsy Drugs in Pipeline, 2024

3.5 Global Epilepsy Therapeutics Market: Dashboard

3.6 Global Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

3.7 Global Epilepsy Therapeutics Market: Market Value Assessment

3.8 Global Epilepsy Therapeutics Market Segmentation: By Generation

3.8.1 Global Epilepsy Therapeutics Market, By Generation Overview

3.8.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Generation

3.8.3 Global Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.8.4 Global Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.8.5 Global Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

3.9 Global Epilepsy Therapeutics Market Segmentation: By Route of Administration

3.9.1 Global Epilepsy Therapeutics Market, By Route of Administration Overview

3.9.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Route of Administration

3.9.3 Global Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

3.9.4 Global Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

3.10 Global Epilepsy Therapeutics Market Segmentation: By Type

3.10.1 Global Epilepsy Therapeutics Market, By Type Overview

3.10.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Type

3.10.3 Global Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

3.10.4 Global Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)



4. Epilepsy Therapeutics Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Epilepsy Therapeutics Market: Historic and Forecast

5.1 Americas Epilepsy Therapeutics Market: Snapshot

5.2 Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.3 Americas Epilepsy Therapeutics Market: Key Factors

5.4 Americas Epilepsy Therapeutics Market: Segment Analysis

5.5 Americas Epilepsy Therapeutics Market Segmentation: By Generation

5.5.1 Americas Epilepsy Therapeutics Market, By Generation Overview

5.5.2 Americas Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

5.5.3 Americas Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

5.5.4 Americas Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

5.6 Americas Epilepsy Therapeutics Market Segmentation: By Route of Administration

5.6.1 Americas Epilepsy Therapeutics Market, By Route of Administration Overview

5.6.2 Americas Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

5.6.3 Americas Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

5.7 Americas Epilepsy Therapeutics Market Segmentation: By Type

5.7.1 Americas Epilepsy Therapeutics Market, By Type Overview

5.7.2 Americas Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

5.7.3 Americas Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)

5.8 Americas Epilepsy Therapeutics Market Segmentation: By Country

5.8.1 Americas Epilepsy Therapeutics Market, by Country Overview

5.8.2 United States Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.2.1 United States Epilepsy Therapeutics Market, By Generation

5.8.2.2 United States Epilepsy Therapeutics Market, By Route of Administration

5.8.2.3 United States Epilepsy Therapeutics Market, By Type

5.8.3 Canada Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.3.1 Canada Epilepsy Therapeutics Market, By Generation

5.8.3.2 Canada Epilepsy Therapeutics Market, By Route of Administration

5.8.3.3 Canada Epilepsy Therapeutics Market, By Type

5.8.4 Rest of Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.4.1 Rest of Americas Epilepsy Therapeutics Market, By Generation

5.8.4.2 Rest of Americas Epilepsy Therapeutics Market, By Route of Administration

5.8.4.3 Rest of Americas Epilepsy Therapeutics Market, By Type



6. Europe Epilepsy Therapeutics Market: Historic and Forecast

6.1 Europe Epilepsy Therapeutics Market: Snapshot

6.2 Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.3 Europe Epilepsy Therapeutics Market: Key Factors

6.4 Europe Epilepsy Therapeutics Market: Segment Analysis

6.5 Europe Epilepsy Therapeutics Market Segmentation: By Generation

6.5.1 Europe Epilepsy Therapeutics Market, By Generation Overview

6.5.2 Europe Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

6.5.3 Europe Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

6.5.4 Europe Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

6.6 Europe Epilepsy Therapeutics Market Segmentation: By Route of Administration

6.6.1 Europe Epilepsy Therapeutics Market, By Route of Administration Overview

6.6.2 Europe Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

6.6.3 Europe Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

6.7 Europe Epilepsy Therapeutics Market Segmentation: By Type

6.7.1 Europe Epilepsy Therapeutics Market, By Type Overview

6.7.2 Europe Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

6.7.3 Europe Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)

6.8 Europe Epilepsy Therapeutics Market Segmentation: By Country

6.8.1 Europe Epilepsy Therapeutics Market, by Country Overview

6.8.2 Germany Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.2.1 Germany Epilepsy Therapeutics Market, By Generation

6.8.2.2 Germany Epilepsy Therapeutics Market, By Route of Administration

6.8.2.3 Germany Epilepsy Therapeutics Market, By Type

6.8.3 United Kingdom Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.3.1 United Kingdom Epilepsy Therapeutics Market, By Generation

6.8.3.2 United Kingdom Epilepsy Therapeutics Market, By Route of Administration

6.8.3.3 United Kingdom Epilepsy Therapeutics Market, By Type

6.8.4 France Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.4.1 France Epilepsy Therapeutics Market, By Generation

6.8.4.2 France Epilepsy Therapeutics Market, By Route of Administration

6.8.4.3 France Epilepsy Therapeutics Market, By Type

6.8.5 Italy Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.5.1 Italy Epilepsy Therapeutics Market, By Generation

6.8.5.2 Italy Epilepsy Therapeutics Market, By Route of Administration

6.8.5.3 Italy Epilepsy Therapeutics Market, By Type

6.8.6 Spain Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.6.1 Spain Epilepsy Therapeutics Market, By Generation

6.8.6.2 Spain Epilepsy Therapeutics Market, By Route of Administration

6.8.6.3 Spain Epilepsy Therapeutics Market, By Type

6.8.7 Rest of Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.7.1 Rest of Europe Epilepsy Therapeutics Market, By Generation

6.8.7.2 Rest of Europe Epilepsy Therapeutics Market, By Route of Administration

6.8.7.3 Rest of Europe Epilepsy Therapeutics Market, By Type



7. Asia Pacific Epilepsy Therapeutics Market: Historic and Forecast

7.1 Asia Pacific Epilepsy Therapeutics Market: Snapshot

7.2 Asia Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.3 Asia Pacific Epilepsy Therapeutics Market: Key Factors

7.4 Asia Pacific Epilepsy Therapeutics Market: Segment Analysis

7.5 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Generation

7.5.1 Asia Pacific Epilepsy Therapeutics Market, By Generation Overview

7.5.2 Asia Pacific Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

7.5.3 Asia Pacific Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

7.5.4 Asia Pacific Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

7.6 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Route of Administration

7.6.1 Asia Pacific Epilepsy Therapeutics Market, By Route of Administration Overview

7.6.2 Asia Pacific Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

7.6.3 Asia Pacific Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

7.7 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Type

7.7.1 Asia Pacific Epilepsy Therapeutics Market, By Type Overview

7.7.2 Asia Pacific Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

7.7.3 Asia Pacific Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)

7.8 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Country

7.8.1 Asia Pacific Epilepsy Therapeutics Market, by Country Overview

7.8.2 China Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.2.1 China Epilepsy Therapeutics Market, By Generation

7.8.2.2 China Epilepsy Therapeutics Market, By Route of Administration

7.8.2.3 China Epilepsy Therapeutics Market, By Type

7.8.3 Japan Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.3.1 Japan Epilepsy Therapeutics Market, By Generation

7.8.3.2 Japan Epilepsy Therapeutics Market, By Route of Administration

7.8.3.3 Japan Epilepsy Therapeutics Market, By Type

7.8.4 India Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.4.1 India Epilepsy Therapeutics Market, By Generation

7.8.4.2 India Epilepsy Therapeutics Market, By Route of Administration

7.8.4.3 India Epilepsy Therapeutics Market, By Type

7.8.5 Rest of Asia Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.5.1 Rest of Asia Pacific Epilepsy Therapeutics Market, By Generation

7.8.5.2 Rest of Asia Pacific Epilepsy Therapeutics Market, By Route of Administration

7.8.5.3 Rest of Asia Pacific Epilepsy Therapeutics Market, By Type



8. Middle East and Africa Epilepsy Therapeutics Market: Historic and Forecast

8.1 Middle East and Africa Epilepsy Therapeutics Market: Snapshot

8.2 Middle East and Africa Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

8.3 Middle East and Africa Epilepsy Therapeutics Market: Key Factors

8.4 Middle East and Africa Epilepsy Therapeutics Market: Segment Analysis

8.5 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Generation

8.5.1 Middle East and Africa Epilepsy Therapeutics Market, By Generation Overview

8.5.2 Middle East and Africa Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR)

8.5.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR)

8.5.4 Middle East and Africa Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR)

8.6 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Route of Administration

8.6.1 Middle East and Africa Epilepsy Therapeutics Market, By Route of Administration Overview

8.6.2 Middle East and Africa Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)

8.6.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)

8.7 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Type

8.7.1 Middle East and Africa Epilepsy Therapeutics Market, By Type Overview

8.7.2 Middle East and Africa Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR)

8.7.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR)



9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Epilepsy Therapeutics Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Industry Ecosystem Analysis

10.1 Porter Analysis



11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Epilepsy Therapeutics Market

11.4 Company Profiles

11.4.1 Novartis

11.4.2 Pfizer

11.4.3 GSK plc.

11.4.4 Merck & Co., Inc.

11.4.5 Johnson & Johnson

11.4.6 Sanofi

11.4.7 Teva Pharmaceuticals

11.4.8 Abbott Laboratories

11.4.9 Jazz Pharmaceuticals

11.4.10 Neurelis, Inc.



12. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Azoth Analytics社の 医療・製薬分野 での最新刊レポート


よくあるご質問


Azoth Analytics社はどのような調査会社ですか?


 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/10/21 10:26

151.56 円

176.95 円

205.98 円

ページTOPに戻る